NJ
New Jersey Senate Bill S3388

New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S3388

Introduced
6/6/24  
Refer
6/6/24  
Report Pass
2/10/25  
Engrossed
2/25/25  
Enrolled
2/27/25  
Chaptered
4/22/25  

Caption

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

Latest NJ S3388 Activity

View All Events: NJ 2024-2025 Regular Session S3388

Companion Bills

NJ A4391

Same As Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

Previously Filed As

NJ A4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

NJ S1325

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ A4545

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ S1213

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ A1853

Requires all prescriptions be transmitted electronically, subject to certain exceptions.

NJ A4114

Requires all prescriptions be transmitted electronically, subject to certain exceptions.

NJ A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

NJ A3186

Regulates Internet pharmacies and electronic prescriptions.

NJ S1131

Regulates Internet pharmacies and electronic prescriptions.

NJ HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

Similar Bills

NJ A4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

NJ A4545

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ S1213

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ S1325

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

CT SB00135

An Act Concerning Revisions To Pharmacy And Drug Control Statutes.

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

NJ A4114

Requires all prescriptions be transmitted electronically, subject to certain exceptions.

NJ A1853

Requires all prescriptions be transmitted electronically, subject to certain exceptions.